Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline

PURPOSE: In the Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management (WISDOM) trial, inhaled corticosteroid (ICS) withdrawal in patients with chronic obstructive pulmonary disease receiving triple therapy (long-acting β(2)-agonist+long-acting muscarinic antagonist+ICS) did not c...

Full description

Saved in:
Bibliographic Details
Published in:Int J Chron Obstruct Pulmon Dis
Main Authors: Ferguson, Gary T, Shaikh, Asif, Tetzlaff, Kay, Mueller, Achim, Magnussen, Helgo, Watz, Henrik
Format: Artigo
Language:Inglês
Published: Dove 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667507/
https://ncbi.nlm.nih.gov/pubmed/33204084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S237408
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items